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46S Abstracts May Supplement 20132.7%), followed by the facial (VII, n ¼ 128, 1.9%), the
vagus (X, n ¼ 49, 0.7%) and the glossopharyngeal (IX,
n ¼ 33, 0.5%) (Table). Patients with perioperative
stroke (0.9%, n ¼ 64) had signiﬁcant higher risk for CNP
(n ¼ 15; CNP risk, 23.4%; P < .001). Length of hospital
stay was longer in patients with a CNP compared to those
without (2 days vs 1.5 day; P < .001). The vast majority
of lesions were transient; only 47 patients (0.7%) had
a persistent CNP. Predictors for CNP were urgent (OR,
1.5; CI, 1.1-2.0; P ¼ .04) and emergent operations (OR,
2.6; CI, 1.2-5.5; P ¼ .02), re-exploration during primary
procedure (OR, 2.0; CI, 1.3-3.0; P ¼ .009) and return to
the operating room (OR, 2.4; CI, 1.4-3.8; P ¼ .004), but
not redo-CEA (OR, 1.0; CI, 0.5-2.1; P ¼ .9) or prior
radiation (OR, 0.9; CI, 0.3-2.5; P ¼ .8).
Conclusions: While the rate of persistent CNP was
low, surgeons should take particular care to protect speciﬁc
nerves in conditions of urgency, re-exploration, and return
to OR.
Table.
Re- Return
Total,
%Urgent,
%Emergent,
%exploration,
%to OR,
%Total
(n ¼
6878)5.6 6.9 16.3 9.7 14.4CN VII 1.9 2.2a 9.3a 2.8 8.1aCN IX 0.5 0.5a 4.7a 0.5 3.6aCN X 0.7 0.9 0 2.8a 4.5aCN XII 2.7 3.1a 11.6a 4.6 4.5aP < .05.
CN, Cranial nerve.
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Objectives: The safety of CAS as an alternative treat-
ment to CEA for carotid occlusive disease remains contro-
versial. Outcomes following these procedures have
previously been deﬁned by randomized trials with carefully
selected patients, institutional studies, and problematic
administrative databases. We sought to utilize a well-vali-
dated national clinical database to compare peri-operativeoutcomes for 2011, the ﬁrst year CAS was captured in
the NSQIP.
Methods: All patients undergoing either CEA or
CAS in 2011 captured by the American College of
Surgeons NSQIP database were identiﬁed. Outcome
measures of interest were 30-day death, stroke, myocar-
dial infarction (MI), reintervention, and readmission
(URA). All statistical analyses were performed using
SAS v9.3.
Results: 4615 patients undergoing CAS (n ¼ 267;
5.9%) or CEA (n ¼ 4248; 94.1%) were included in the
analysis. Median age was 71 years. 6.1% of patients had
symptomatic disease. The CAS cohort were younger (P
< .01), more frequently female (P < .01), less hypertensive
(P < .01), and had better preoperative ASA scores (P <
.01), but were more frequently coagulopathic (P < .01).
30-day death was signiﬁcantly higher in patients under-
going CAS cf. CEA (n ¼ 5, 1.9% vs n ¼ 24, 0.6%. P ¼
.03). There was no association between surgical approach
and perioperative stroke, MI, reintervention or URA.
Nonvascular surgeon status was associated with increased
mortality (P ¼ .02), as was preoperative dyspnea (P ¼
.03), heart failure (P ¼ .03), and dialysis (P < .01). Risk
factors for stroke included preadmission status (P ¼ .04)
and need for emergency surgery (P ¼ .02). Patients under-
going CAS had a signiﬁcantly shorter length of stay
(median, 1; range, 0-24 days vs 1, 0-91 days; P < .01).
Conclusions: Based on a national cohort of patients
from this large clinical database, CAS was associated
with higher 30-day mortality than CEA. Vascular
surgeons performed both procedures more safely than
other specialists.
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Objectives: To present and evaluate a novel technique
for carotid body tumor (CBT) surgery.
Methods: The craniocaudal dissection technique is
based upon early identiﬁcation of the vagal, hypo-
glossal, and facial nerves, control of the internal carotid
artery, and ligation of the ascending pharyngeal artery,
all at the CBT’s cranial side. Thereafter, with optimal
control over neurovascular structures, dissection is
carried out in a cranial to caudal fashion. A retrospec-
tive analysis of all craniocaudally operated CBT patients
in the past 20 years was carried out and results were
compared to the current literature describing results
from the conventional (caudal to cranial) operative
technique.
Results: Ninety CBTs were removed in 77 patients
(53% female, mean age 41 years). There were 20
